The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma

References

• Stiller CA, Trama A, Serraino D, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49(3):684–695. doi:10.1016/j.ejca.2012.09.011.
   PubMed Web of Science ®Google Scholar
• Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.
   PubMedGoogle Scholar
• Balamuth NJ, Womer RB. Ewing’s sarcoma. Lancet Oncol. 2010;11(2):184–192. doi:10.1016/S1470-2045(09)70286-4.
   PubMed Web of Science ®Google Scholar
• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21 Suppl 7(Suppl 7):vii320–5. doi:10.1093/annonc/mdq276.
   PubMedGoogle Scholar
• Stahl M, Ranft A, Paulussen M, et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer. 2011;57(4):549–553. doi:10.1002/pbc.23040.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Luksch R, Hall KS, et al. Post-relapse survival in patients with Ewing sarcoma. Pediatr Blood Cancer. 2015;62(6):994–999. doi:10.1002/pbc.25388.
   PubMed Web of Science ®Google Scholar
• Sankar S, Lessnick SL. Promiscuous partnerships in Ewing’s sarcoma. Cancer Genet. 2011;204(7):351–365. doi:10.1016/j.cancergen.2011.07.008.
   PubMed Web of Science ®Google Scholar
• Ferguson JL, Turner SP. Bone cancer: diagnosis and treatment principles. Am Fam Physician. 2018;98(4):205–213.
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Lewis VO, Satcher RL, Moon BS, Lin PP. What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res. 2014;472(10):3188–3195. doi:10.1007/s11999-014-3759-7.
   PubMed Web of Science ®Google Scholar
• McHugh K, Roebuck DJ. Pediatric oncology surveillance imaging: two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up. Pediatr Blood Cancer. 2014;61(1):3–6. doi:10.1002/pbc.24757.
   PubMed Web of Science ®Google Scholar
• Kasalak Ö, Dammann A, Adams HJA, et al. Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile. Skelet Radiol. 2018;47(11):1517–1522. doi:10.1007/s00256-018-2966-9.
   PubMed Web of Science ®Google Scholar
• Morgan JE, Walker R, Harden M, Phillips RS. A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors. Cancer Med. 2020;9(14):4949–4961. doi:10.1002/cam4.3110.
   PubMed Web of Science ®Google Scholar
• Heinemann M, Ranft A, Langer T, et al. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Pediatr Blood Cancer. 2018;65(7):e27011. doi:10.1002/pbc.27011.
   PubMed Web of Science ®Google Scholar
• Lakkis F, Alaiwi SA, Naffaa L, et al. Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018;65(1):26723. doi:10.1002/pbc.26723.
   Web of Science ®Google Scholar
• Vaarwerk B, Limperg PF, Naafs-Wilstra MC, Merks JHM, Grootenhuis MA. Getting control during follow-up visits: the views and experiences of parents on tumor surveillance after their children have completed therapy for rhabdomyosarcoma or Ewing sarcoma. Support Care Cancer. 2019;27(10):3841–3848. doi:10.1007/s00520-019-04678-4.
   PubMed Web of Science ®Google Scholar
• Biermann JS, Chow W, Reed DR, et al. NCCN guidelines insights: bone cancer, Version 2.2017. J Natl Compr Canc Netw. 2017;15(2):155–167. doi:10.6004/jnccn.2017.0017.
   PubMed Web of Science ®Google Scholar
• Puri A, Gulia A, Hawaldar R, Ranganathan P, Badwe RA. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014;472(5):1568–1575. doi:10.1007/s11999-013-3385-9.
   PubMed Web of Science ®Google Scholar
• Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv79–iv95. doi:10.1093/annonc/mdy310.
   PubMedGoogle Scholar
• Schrøder H, Rechnitzer C, Wehner PS, et al. Danish childhood cancer registry. Clin Epidemiol. 2016;8:461–464. doi:10.2147/CLEP.S99508.
   PubMed Web of Science ®Google Scholar
• Juergens C, Weston C, Lewis I, et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer. 2006;47(1):22–29. doi:10.1002/pbc.20820.
   PubMed Web of Science ®Google Scholar
• Bielack SS, Smeland S, Whelan JS, et al. Methotrexate, doxorubicin, and cisplatin (map) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results of the EURAMOS-1 good response randomized controlled trial. j Clin Oncol. 2015;33(20):2279–2287. doi:10.1200/JCO.2014.60.0734.
   PubMed Web of Science ®Google Scholar
• Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C, Studer UE. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol. 2010;58(4):486–494. doi:10.1016/j.eururo.2010.05.041.
   PubMed Web of Science ®Google Scholar
• Park VY, Kim EK, Kim MJ, Moon HJ, Yoon JH. Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: outcomes stratified by interval between definitive surgery and surveillance MR imaging. BMC Cancer. 2018;18(1):91. doi:10.1186/s12885-018-3998-1.
   PubMedGoogle Scholar
• Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol. 2017;146(1):3–10. doi:10.1016/j.ygyno.2017.03.022.
   PubMed Web of Science ®Google Scholar
• Young DW. What does an MRI scan cost? Healthc Financ Manage. 2015;69(11):46–49.
   PubMedGoogle Scholar
• Kim CR, Kim B, Ning MS, et al. Cost analysis of PET/CT versus CT as surveillance for stage III non-small-cell lung cancer after definitive radiation therapy. Clin Lung Cancer. 2018;19(4):e517–e28. doi:10.1016/j.cllc.2018.03.012.
   PubMed Web of Science ®Google Scholar
• Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499–505. doi:10.1016/S0140-6736(12)60815-0.
   PubMed Web of Science ®Google Scholar
• Brasme JF, Chalumeau M, Oberlin O, Valteau-Couanet D, Gaspar N. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients. J Clin Oncol. 2014;32(18):1935–1940. doi:10.1200/JCO.2013.53.8058.
   PubMed Web of Science ®Google Scholar